Uganda: Quality Chemicals to Produce New Aids Drug
By Racheal Ninsiima, 17 February 2013
Ugandan firm Quality Chemicals Industrial Limited (QCIL) plans to produce Duomune as a new anti-retroviral drug, that will be taken a single tablet, rather than in combination with others.
QCIL says the recommended dose of Duomune is one tablet, taken orally, once daily with food. It is designed for adults above the age of 18. QCIL Executive Director Emmanuel Katongole says production begins in May after QCIL has secured the National Drugs Authority approval.
Copyright © 2013 The Observer. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com).
To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.
AllAfrica publishes around 2,000 reports a day from more than 130 news organizations and over 200 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.